期刊文献+

乙型肝炎病毒基因突变与肝癌的相关性研究进展

Correlation of hepatitis B virus mutation and hepatocellular carcinoma:review of recent progress
原文传递
导出
摘要 原发性肝细胞癌(HCC)是最常见的6种肿瘤疾病之一,在肿瘤致死因素中占第3位,可以导致每年600万人死亡,严重威胁人类健康。HCC的发病机制迄今尚未完全确定,一般认为是多种因素共同作用的结果。而全世界75%~80%的HCC与慢性病毒性肝炎的进展相关[1]。在我国这个比例更高,且大部分与乙型肝炎(乙肝)病毒(hepatitis B virus,HBV)感染有关。已经研究证实持续HBeAg阳性和高HBV DNA水平是HCC的独立危险因素。而对于阴性的慢性乙型肝炎患者。 In China, the majority of hepatocellular carcinoma (HCC) is associated with chronic hepatitis B infection. It suggested that HBV gene mutations could increase the risk of HCC. In this review, we summarize recent research progress in hepatitis B virus (HBV) gene mutations at different regions (S, C, P and X ORFs) and the correlation with HCC.
作者 黄玲 许洁
出处 《中国病毒病杂志》 CAS 2014年第1期76-80,共5页 Chinese Journal of Viral Diseases
关键词 原发性肝癌 乙型肝炎病毒 突变 Hepatocellular carcinoma Hepatitis B virus Mutation
  • 相关文献

参考文献1

二级参考文献16

  • 1黄月华,王战会,曾国兵,马世武,侯金林.广东地区原发性肝癌与乙型肝炎病毒基因型的相关性[J].中华传染病杂志,2007,25(4):215-218. 被引量:6
  • 2Marie Matsuda,Fumitaka Suzuki,Yoshiyuki Suzuki,Akihito Tsubota,Norio Akuta,Tetsuya Hosaka,Takashi Someya,Masahiro Kobayashi,Satoshi Saitoh,Yasuji Arase,Junko Satoh,Kimiko Takagi,Mariko Kobayashi,Kenji Ikeda,Hiromitsu Kumada.Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine[J].Journal of Gastroenterology.2004(1)
  • 3Moskovitz DN,Osiowy C,Giles E,et al.Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance[].Journal of Viral Hepatitis.2005
  • 4Lai CL,Dienstag J,Schiff E,et al.Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B[].Clinical Infectious Diseases.2003
  • 5Liaw YF,Chien RN,Yeh CT,et al.Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy[].Hepatology.1999
  • 6Liaw YF,Chien RN,Yeh CT.No benefit to continue lamivudine therapy after emergence of YMDD mutations[].Antiviral Therapy.2004
  • 7Kobayashi S,Ide T,Sata M.Detection of YMDD motif mutation in some lamivudine-untreated asymptomatic hepatitis B virus carriers[].Journal of Hepatology.2001
  • 8Bruix J,Sherman M.Management of hepatocellular carcinoma[].Hepatology.2005
  • 9Liang X,Bi S,Yang W,Wang L,Cui G,Cui F,Zhang Y,Liu J,Gong X,Chen Y,Wang F,Zheng H,Wang F,Guo J,Jia Z,Ma J,Wang H,Luo H,Li L,Jin S,Hadler SC,Wang Y.Epidemiologi-cal serosurvey of hepatitis B in China--declining HBV preva-lence due to hepatitis B vaccination[].Vaccine.2009
  • 10Liang X,Bi S,Yang W,Wang L,Cui G,Cui F,Zhang Y,Liu J,Gong X,Chen Y,Wang F,Zheng H,Wang F,Guo J,Jia Z,Ma J,Wang H,Luo H,Li L,Jin S,Hadler SC,Wang Y.Evaluation of the impact of hepatitis B vaccination among children born during1992-2005in China[].The Journal of Infectious Diseases.2009

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部